These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9224971)

  • 21. Immune reaction to breast cancer: for better or for worse?
    Ogmundsdóttir HM
    Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 2():S75-81. PubMed ID: 11665751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of organ-specific fibroblasts on proliferation and differentiation of breast cancer cells.
    Yashiro M; Ikeda K; Tendo M; Ishikawa T; Hirakawa K
    Breast Cancer Res Treat; 2005 Apr; 90(3):307-13. PubMed ID: 15830145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
    Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
    Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Screening of a sub-clone of human breast cancer cells with high metastasis potential].
    Ye LH; Wu LY; Guo W; Ma HT; Zhang XD
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):61-5. PubMed ID: 16606541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficiency of connexin43 gap junctions is an independent marker for breast tumors.
    Laird DW; Fistouris P; Batist G; Alpert L; Huynh HT; Carystinos GD; Alaoui-Jamali MA
    Cancer Res; 1999 Aug; 59(16):4104-10. PubMed ID: 10463615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo.
    Lapteva N; Yang AG; Sanders DE; Strube RW; Chen SY
    Cancer Gene Ther; 2005 Jan; 12(1):84-9. PubMed ID: 15472715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
    Krüger A; Soeltl R; Lutz V; Wilhelm OG; Magdolen V; Rojo EE; Hantzopoulos PA; Graeff H; Gänsbacher B; Schmitt M
    Cancer Gene Ther; 2000 Feb; 7(2):292-9. PubMed ID: 10770639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation and breast cancer.
    Russo J; Russo IH
    Medicina (B Aires); 1997; 57 Suppl 2():81-91. PubMed ID: 9567346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunologic consequences of laparoscopy in oncology.
    Carter JJ; Whelan RL
    Surg Oncol Clin N Am; 2001 Jul; 10(3):655-77. PubMed ID: 11685934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancer.
    Núñez NP; Jelovac D; Macedo L; Berrigan D; Perkins SN; Hursting SD; Barrett JC; Brodie A
    Clin Cancer Res; 2004 Aug; 10(16):5375-80. PubMed ID: 15328175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts.
    Paulus P; Stanley ER; Schäfer R; Abraham D; Aharinejad S
    Cancer Res; 2006 Apr; 66(8):4349-56. PubMed ID: 16618760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.
    Urquidi V; Sloan D; Kawai K; Agarwal D; Woodman AC; Tarin D; Goodison S
    Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo.
    Dewan MZ; Terunuma H; Takada M; Tanaka Y; Abe H; Sata T; Toi M; Yamamoto N
    Breast Cancer Res Treat; 2007 Sep; 104(3):267-75. PubMed ID: 17066321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological enhancement of breast cancer.
    Stewart TH; Heppner GH
    Parasitology; 1997; 115 Suppl():S141-53. PubMed ID: 9571699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenesis and oncogenesis.
    Gullino PM
    J Natl Cancer Inst; 1978 Sep; 61(3):639-43. PubMed ID: 357745
    [No Abstract]   [Full Text] [Related]  

  • 40. ISG15 implicated in cytoskeleton disruption and promotion of breast cancer.
    Hadjivasiliou A
    Expert Rev Proteomics; 2012; 9(1):7. PubMed ID: 22397023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.